Author details

Full Name

Manuela Gariboldi

Affiliation

ORCID

Career Start Year

1987

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37500685	Correlation between biological and mechanical properties of extracellular matrix from colorectal peritoneal metastases in human tissues.		2023
36460033	Decellularized extracellular matrix as scaffold for cancer organoid cultures of colorectal peritoneal metastases.	Journal of Molecular Cell Biology	2023
36726208	Peritoneal fluid COVID-19 testing in patients with a negative nasopharyngeal swab: prospective study.	Br J Surg	2023
34931559	Exploring the association with disease recurrence of miRNAs predictive of colorectal cancer.	International Journal of Biological Markers	2022
35794137	Gut microbiota composition in colorectal cancer patients is genetically regulated.	Scientific Reports	2022
35336366	Force Sensing on Cells and Tissues by Atomic Force Microscopy.	Sensors	2022
34253565	Preventive Anti-inflammatory Diet to Reduce Gastrointestinal Inflammation in Familial Adenomatous Polyposis Patients: A Prospective Pilot Study.	Cancer Prevention Research	2021
34209683	Mediterranean Diet to Prevent the Development of Colon Diseases: A Meta-Analysis of Gut Microbiota Studies.	Nutrients	2021
31304978	Plasma miRNA-based signatures in CRC screening programs.	International Journal of Cancer	2020
32934879	Trial watch : the gut microbiota as a tool to boost the clinical efficacy of anticancer immunotherapy.	Oncoimmunology	2020
31055940	A Pilot Low-Inflammatory Dietary Intervention to Reduce Inflammation and Improve Quality of Life in Patients With Familial Adenomatous Polyposis: Protocol Description and Preliminary Results.	Integrative Cancer Therapies	2019
28114961	MIF/CD74 axis is a target for novel therapies in colon carcinomatosis.	Journal of Experimental and Clinical Cancer Research	2017
29167573	Metformin transiently inhibits colorectal cancer cell proliferation as a result of either AMPK activation or increased ROS production.	Scientific Reports	2017
28123561	A methodological procedure for evaluating the impact of hemolysis on circulating microRNAs.	Oncology Letters	2017
26811605	Integration of genome scale data for identifying new players in colorectal cancer.		2016
27100729	Comment on 'Circulating cell-free miRNAs as biomarker for triple-negative breast cancer'-Methodological challenges in combining miRNAs as circulating biomarkers.	British Journal of Cancer	2016
26919240	miR-342 overexpression results in a synthetic lethal phenotype in BRCA1-mutant HCC1937 breast cancer cells.	Oncotarget	2016
26012475	The Effects of miR-20a on p21: Two Mechanisms Blocking Growth Arrest in TGF-Î²-Responsive Colon Carcinoma.	Journal of Cellular Physiology	2015
25704507	Moving from discovery to validation in circulating microRNA research.	International Journal of Biological Markers	2015
25782327	DPD and UGT1A1 deficiency in colorectal cancer patients receiving triplet chemotherapy with fluoropyrimidines, oxaliplatin and irinotecan.	British Journal of Clinical Pharmacology	2015
24892985	NqA: an R-based algorithm for the normalization and analysis of microRNA quantitative real-time polymerase chain reaction data.	Analytical Biochemistry	2014
24456927	Combined analysis of chromosomal instabilities and gene expression for colon cancer progression inference.	Journal of Clinical Bioinformatics	2014
24150995	A normalization strategy for the analysis of plasma microRNA qPCR data in colorectal cancer.	International Journal of Cancer	2014
24379162	Activity of temozolomide in patients with advanced chemorefractory colorectal cancer and MGMT promoter methylation.	Annals of Oncology	2014
24423916	Circulating miR-378 in plasma: a reliable, haemolysis-independent biomarker for colorectal cancer.	British Journal of Cancer	2014
24475217	miR-342 regulates BRCA1 expression through modulation of ID4 in breast cancer.	PLoS One	2014
24852853	Circulating free DNA in a screening program for early colorectal cancer detection.	Tumori	2014
23697628	Gold-nanoparticle-based colorimetric discrimination of cancer-related point mutations with picomolar sensitivity.	ACS Nano	2013
22665053	Targeting metabolism for cancer treatment and prevention: metformin, an old drug with multi-faceted effects.	Oncogene	2013
24005867	Role of cMET in the development and progression of colorectal cancer.	International Journal of Molecular Sciences	2013
23564763	A review on biomarkers for prediction of treatment outcome in gastric cancer.	Anticancer Research	2013
21351098	Methylation status in patients with early stage colon cancer: a new prognostic marker?	International Journal of Cancer	2012
22343615	miRNA profiling in colorectal cancer highlights miR-1 involvement in MET-dependent proliferation.	Molecular Cancer Research	2012
22140532	ERG deregulation induces PIM1 over-expression and aneuploidy in prostate epithelial cells.	PLoS ONE	2011
20715112	Transcriptional characteristics of familial non-BRCA1/BRCA2 breast tumors.	Int J Cancer	2011
20625818	Gene expression analysis reveals a different transcriptomic landscape in female and male breast cancer.	Breast Cancer Res Treat	2011
20589936	Chromosome band 17q21 in breast cancer: significant association between beclin 1 loss and HER2/NEU amplification.	Genes Chromosomes and Cancer	2010
21154162	Molecularly targeted therapies for colorectal cancer: Strategies for implementing translational research in clinical trials.		2010
19826428	Gene expression profiling integrated into network modelling reveals heterogeneity in the mechanisms of BRCA1 tumorigenesis.	Br J Cancer	2009
19440381	Misbehaviour of XIST RNA in breast cancer cells.	PLoS One	2009
19211196	To bleed or not to bleed. A prediction based on individual gene profiling combined with dose-volume histogram shapes in prostate cancer patients undergoing three-dimensional conformal radiation therapy.	International Journal of Radiation Oncology Biology Physics	2009
19672874	Integrative approach for prioritizing cancer genes in sporadic colon cancer.	Genes Chromosomes and Cancer	2009
18332874	Metallothionein 1G acts as an oncosupressor in papillary thyroid carcinoma.	Laboratory Investigation	2008
17914668	Invasiveness gene signature predicts a favorable outcome also in estrogen receptor-positive primary breast cancers treated with adjuvant tamoxifen.	Breast Cancer Research and Treatment	2008
18477803	Re: Molecular basis for estrogen receptor alpha deficiency in BRCA1-linked breast cancer.	J Natl Cancer Inst	2008
18508997	Patterns and changes in gene expression following neo-adjuvant anti-estrogen treatment in estrogen receptor-positive breast cancer.	Endocr Relat Cancer	2008
18000217	Challenges in projecting clustering results across gene expression-profiling datasets.	J Natl Cancer Inst	2007
17213814	Analysis of gene expression identifies PLAB as a mediator of the apoptotic activity of fenretinide in human ovarian cancer cells.	Oncogene	2007
16829123	Molecular predictors of response and outcome in ovarian cancer.	Critical Reviews in Oncology/Hematology	2006
16698233	Transcriptional network dynamics in macrophage activation.	Genomics	2006